Small CAp Active Runners: Inovio Pharmaceuticals (NYSEMKT:INO), Walter Energy (NYSE:WLT), EXACT Sciences Corporation (NASDAQ:EXAS), Western Asset Mortgage Capital (NYSE:WMC)

Inovio Pharmaceuticals Inc (NYSEMKT:INO) announced the appointment of E.J. Brandreth as vice president of quality. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -5.71% in last session and finished the day at $3.14. Traded volume was 9.33million shares in the last session and the average volume of the stock remained 7.54million shares. The beta of the stock remained 3.71. Inovio Pharmaceuticals Inc (NYSEMKT:INO) insider ownership is … Continue reading Small CAp Active Runners: Inovio Pharmaceuticals (NYSEMKT:INO), Walter Energy (NYSE:WLT), EXACT Sciences Corporation (NASDAQ:EXAS), Western Asset Mortgage Capital (NYSE:WMC)

Biotech Bearish Stocks: MannKind Corporation (NASDAQ:MNKD), Exelixis (NASDAQ:EXEL), Inovio Pharmaceuticals (NYSEMKT:INO), EXACT Sciences (NASDAQ:EXAS)

An FDA report raised questions regarding Mannkind Corporation (NASDAQ:MNKD)’s diabetes device Afrezza ahead of an April 1 meeting of outside advisers to the FDA. The drug has yet to be approved by the FDA as there are concerns over certain pharmacology issues that could impact Afreeza’s safety and effectiveness. MannKind Corporation (NASDAQ:MNKD) stock performance was -7.12% in last session and finished the day at $4.83. … Continue reading Biotech Bearish Stocks: MannKind Corporation (NASDAQ:MNKD), Exelixis (NASDAQ:EXEL), Inovio Pharmaceuticals (NYSEMKT:INO), EXACT Sciences (NASDAQ:EXAS)

Trade-Ideas LLC identified Inovio Pharmaceuticals Inc (NYSEMKT:INO) as a “barbarian at the gate” (strong stocks crossing above resistance with today’s range greater than 200%) candidate. Inovio Pharmaceuticals, Inc. (NYSEMKT:INO), together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. Currently there are 3 analysts that rate Inovio Pharmaceuticals Inc (NYSEMKT:INO) a buy, no … Continue reading Biotech Gainers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), Dyax (NASDAQ:DYAX)

Pfizer Inc. (NYSE:PFE) announced encouraging top-line data from a phase IIIb study evaluating Genotropin for increasing height in small-for-gestational-age (SGA) children aged between 24 and 30 months. Pfizer Inc. (NYSE:PFE) stock performance was -0.25% in last session and finished the day at $32.10. Traded volume was 27.74million shares in the last session and the average volume of the stock remained 26.63million shares. The beta of … Continue reading Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Inovio Pharmaceuticals (NYSEMKT:INO), Johnson & Johnson (NYSE:JNJ)

On March 18, 2014, GTT Communications, Inc. (NYSEMKT:GTT) issued a press release relating to the fourth quarter and year ended December 31, 2013 financial results. GTT Communications Inc. (NYSEMKT:GTT) stock performance was 11.86% in last session and finished the day at $10.85. Traded volume was 120,166.00 shares in the last session and the average volume of the stock remained 112,980.00 shares. The beta of the … Continue reading Bullish Stocks: GTT Communications (NYSEMKT:GTT), MEI Pharma (NASDAQ:MEIP), Inovio Pharmaceuticals Inc. (NYSEMKT:INO), CONN’S (NASDAQ:CONN)

Earlier this week, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced that it has initiated a phase II pivotal study that will evaluate the safety and efficacy of AP26113 in locally advanced or metastatic non-small cell lung cancer (NSCLC) in patients who had previously been treated with Pfizer’s (PFE – Analyst Report) Xalkori (crizotinib). Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was -1.16% in last session and finished the … Continue reading Biotech Active Movers: Ariad Pharmaceuticals (NASDAQ:ARIA), Insmed Incorporated (NASDAQ:INSM), Rexahn Pharmaceuticals (NYSEMKT:RNN), Inovio Pharmaceuticals (NYSEMKT:INO)